The Coaltion for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...

Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

Which bank is better for your business Novo or Chase? This video breaks down the key differences between Novo’s digital-first, fee-free banking for freelancers and e-commerce businesses, and Chase’s ...

Vienna, Austria – May 9th 2025 – Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its ...

As Novo Nordisk works through a period of transition in the U.S. GLP-1 drug market, sales from the company's star obesity ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, ...

It covers various aspects of network automation, including Plug and Play (PnP) workflows, onboarding and day-N templates, and the use of Velocity and Jinja2 scripting languages.

The US FDA has accepted Novo Nordisk’s new drug application (NDA) submission for the 25 mg oral formulation of Wegovy ...